HomeNewsArvind vasudeva

Arvind Vasudeva

Jump to

Aurobindo Pharma earmarks Rs 900 crore capex for 2015-16

Elaborating on the capital expenditure plans during the current fiscal, he said the company is continuing to invest in enhancing finished dosage as well as active pharmaceutical ingredient (API) capacity.
Why these 8 pharma CEOs will be on investors radar in '14

GV Prasad Reddy and Satish Reddy of Dr Reddy's Labs have a big task at hand - large business restructuring process, reorientation of operations and increasing focus on global markets.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Arvind Vasudeva

Aurobindo Pharma earmarks Rs 900 crore capex for 2015-16

Why these 8 pharma CEOs will be on investors radar in '14